Scribe Therapeutics (SCTX) Earnings Date & Reports
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SCTX is expected to report earnings to fall 89.06% to -41 cents per share on December 02
Q3'26
Est.
$-0.42
Q2'26
Beat
by $2.36
The last earnings report on September 02 showed earnings per share of -383 cents, beating the estimate of -619 cents. With 103.84K shares outstanding, the current market capitalization sits at 365.38M.